LAS VEGAS / Oct 23, 2024 / Business Wire / Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based AI, will be attending two upcoming investor events: the Emerging Growth Conference on October 30-31, 2024; and the Sidoti Small-Cap Conference, taking place on November 13-14, 2024. These conferences represent opportunities for Realbotix to build market awareness with retail and institutional investors.

“Having completed our acquisition and rebrand to Realbotix in July of this year, there is still a high degree of unawareness about us,” said Andrew Kiguel, CEO. “Attending conferences is an excellent way for us to connect to a large number of investors to highlight what we are working on.”

At both events, Realbotix’s management will walk through the Company’s investor deck, also available at Realbotix.Ai, and its vision for the future of robotics and artificial intelligence.

Emerging Growth Conference
Date: October 30-31, 2024
The Emerging Growth Conference is known for attracting forward-thinking investors focused on high-growth sectors, making it an ideal venue for Realbotix to articulate its vision. The event will offer a comprehensive platform for the company to showcase why AI-enabled humanoid robotics represents one of the most significant technological advancements of the next decade.

Sidoti Small-Cap Conference
Date: November 13-14, 2024
The Sidoti Small-Cap Virtual Conference is renowned for bringing together institutional investors and emerging small-cap companies with high-growth potential. For Realbotix, this platform provides a chance to highlight the company's innovative solutions and connect with prominent investors who are keen to explore the next generation of disruptive technologies.

Realbotix’s participation in these events reflects its commitment to building market awareness.

For more information about Realbotix please visit www.realbotix.ai.

About Realbotix

Transcending the barrier between man and machine, Realbotix creates human-like, socially intelligent robots that improve the human experience through learning, connection and play. Manufactured in Nevada, USA, Realbotix has built a reputation for building robots with the most realistic human appearance on the market. Our target addressable markets are massive, most of them in the tens or hundreds of billions USD.

Our mission is to create robots and AI that are indistinguishable from humans in appearance and social interaction. Realbotix replicates the physical and emotional aspects of being human, in hardware and software. This versatility makes our robots and their personalities customizable and programmable to suit a wide variety of use cases.

Visit Realbotix.AI to learn more.

Keep up-to-date on Realbotix.AI developments and join our online communities on Twitter, LinkedIn, and YouTube.

Follow Aria, our humanoid robot, on Instagram and TikTok.

Forward-Looking Statements

Forward-Looking Statements This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions. Forward looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in our securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.